AR and cancer: However, it is not clear whether TRIM24 induces the ER, AR, and STAT3 pathways in p53-highly mutated cancers, such as epithelial ovarian cancer, and, if so, what is the consequence if TRIM24 activates those oncogenic signaling pathways on one hand and suppresses mtp53 on the other?